PKC NVR Pill - orange capsule/oblong, 25mm
Generic Name: midostaurin
Pill with imprint PKC NVR is Orange, Capsule/Oblong and has been identified as Rydapt 25 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Rydapt is used in the treatment of Acute Myeloid Leukemia; Systemic Mastocytosis and belongs to the drug class multikinase inhibitors. Rydapt 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PKC NVR
Rydapt
- Generic Name
- midostaurin
- Imprint
- PKC NVR
- Strength
- 25 mg
- Color
- Orange
- Size
- 25.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0698
- Inactive Ingredients
-
polyoxyl 40 hydrogenated castor oil,
polyethylene glycol 400,
glycerin,
alcohol,
corn oil,
titanium dioxide,
alpha-tocopherol,
ferric oxide yellow,
ferric oxide red,
carmine,
propylene glycol,
water
Note: Inactive ingredients may vary.
See also:
Prilosec
Prilosec (omeprazole) is used to treat symptoms of GERD and other conditions caused by excess ...
Prevacid
Prevacid is used to treat and prevent stomach and intestinal ulcers. Learn about side effects ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Revuforj
Revuforj is used to treat acute leukemia with a lysine methyltransferase 2A gene translocation ...
More about Rydapt (midostaurin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.